))
Discovering Monderna's new landscape for vaccines in Europe
Manage episode 362892171 series 3450218
Content provided by EURACTIV. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by EURACTIV or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
This week, EURACTIV’s health team talks with Chantal Friebertshäuser, Senior Vice President at Moderna for Europe, the Middle East and Canada. They discuss the end of COVID and the new vaccine they are developing against cancer.
They also talk about the new facility the biotechnology company recently opened in Madrid, Spain. This new laboratory, equipped with the latest technology, is the biggest end-to-end production hub for Moderna outside the United States.
22 episodes
Share
